{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,7]],"date-time":"2026-11-07T02:07:13Z","timestamp":1794017233197,"version":"4.8.0"},"reference-count":64,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100009074","name":"Huaiyin Institute of Technology","doi-asserted-by":"publisher","award":["Z301B21529"],"award-info":[{"award-number":["Z301B21529"]}],"id":[{"id":"10.13039\/501100009074","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002857","name":"China Pharmaceutical University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002857","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["22201091"],"award-info":[{"award-number":["22201091"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100013061","name":"Jilin Provincial Scientific and Technological Development Program","doi-asserted-by":"publisher","award":["YDZJ202401655ZYTS"],"award-info":[{"award-number":["YDZJ202401655ZYTS"]}],"id":[{"id":"10.13039\/501100013061","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Inorganic Biochemistry"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1016\/j.jinorgbio.2026.113295","type":"journal-article","created":{"date-parts":[[2026,3,8]],"date-time":"2026-03-08T15:40:33Z","timestamp":1772984433000},"page":"113295","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Multifunctional platinum(IV) complexes reverse cisplatin resistance in triple- negative breast cancer via ferroptosis and apoptosis"],"prefix":"10.1016","volume":"280","author":[{"given":"Guoxiu","family":"Cao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junjie","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuhan","family":"Qian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yong","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weiwei","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaochao","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qingqing","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhikun","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.jinorgbio.2026.113295_bb0005","doi-asserted-by":"crossref","first-page":"2786","DOI":"10.1038\/s41467-025-57988-z","article-title":"Dynamic ctDNA tracking stratifies relapse risk for triple negative breast cancer patients receiving neoadjuvant chemotherapy","volume":"16","author":"Li","year":"2025","journal-title":"Nat. Commun."},{"issue":"32","key":"10.1016\/j.jinorgbio.2026.113295_bb0010","doi-asserted-by":"crossref","DOI":"10.1002\/smll.202502419","article-title":"Tumor-targeted radioiodinated glyconanoparticles for doxorubicin delivery and auger-chemotherapy in triple-negative breast cancer","volume":"21","author":"Suman","year":"2025","journal-title":"Small"},{"issue":"14","key":"10.1016\/j.jinorgbio.2026.113295_bb0015","doi-asserted-by":"crossref","DOI":"10.1002\/advs.202413121","article-title":"HDAC2-mediated METTL3 delactylation promotes DNA damage repair and chemotherapy resistance in triple-negative breast cancer","volume":"12","author":"He","year":"2025","journal-title":"Adv. Sci."},{"key":"10.1016\/j.jinorgbio.2026.113295_bb0020","doi-asserted-by":"crossref","DOI":"10.1016\/j.jconrel.2025.114019","article-title":"The impact of peptide surface density on PD-L1 receptor inhibition as a therapeutic strategy for triple negative breast cancer","volume":"385","author":"Keshishian","year":"2025","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jinorgbio.2026.113295_bb0025","doi-asserted-by":"crossref","first-page":"1796","DOI":"10.3390\/pharmaceutics15071796","article-title":"Triple negative breast cancer treatment options and limitations: future outlook","volume":"15","author":"Obidiro","year":"2023","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.jinorgbio.2026.113295_bb0030","doi-asserted-by":"crossref","first-page":"1625","DOI":"10.1021\/acs.jmedchem.3c01089","article-title":"Targeting the oxytocin receptor for breast cancer management: a niche for peptide tracers","volume":"67","author":"Kalaba","year":"2024","journal-title":"J. Med. Chem."},{"issue":"11","key":"10.1016\/j.jinorgbio.2026.113295_bb0035","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1007\/s11864-017-0506-9","article-title":"Role of platinum in early-stage triple-negative breast cancer","volume":"18","author":"La Belle","year":"2017","journal-title":"Curr. Treat. Options in Oncol."},{"key":"10.1016\/j.jinorgbio.2026.113295_bb0040","doi-asserted-by":"crossref","DOI":"10.1016\/j.breast.2024.103712","article-title":"Platinum chemotherapy for early triple-negative breast cancer","volume":"75","author":"Mason","year":"2024","journal-title":"Breast"},{"key":"10.1016\/j.jinorgbio.2026.113295_bb0045","article-title":"Pyroptosis-inducing platinum(IV) prodrugs via GSDME pathway for chemoimmunotherapy and metastasis inhibition in triple-negative breast cancer","volume":"12","author":"Yang","year":"2025","journal-title":"Adv. Sci."},{"issue":"24","key":"10.1016\/j.jinorgbio.2026.113295_bb0050","doi-asserted-by":"crossref","first-page":"16099","DOI":"10.1021\/acs.jmedchem.2c01352","article-title":"Multi-therapies based on PARP inhibition: potential therapeutic approaches for cancer treatment","volume":"65","author":"Zhang","year":"2022","journal-title":"J. Med. Chem."},{"issue":"19","key":"10.1016\/j.jinorgbio.2026.113295_bb0055","doi-asserted-by":"crossref","first-page":"20340","DOI":"10.1021\/acs.jmedchem.5c01395","article-title":"Development of ciprofibrate platinum(IV) nanodrugs as antimetastatic agents with COFs as carriers","volume":"68","author":"Feng","year":"2025","journal-title":"J. Med. Chem."},{"issue":"16","key":"10.1016\/j.jinorgbio.2026.113295_bb0060","doi-asserted-by":"crossref","first-page":"17065","DOI":"10.1021\/acs.jmedchem.5c00543","article-title":"Mitochondria-targeted benzoxazole-based platinum photosensitizer complexes: photophysical properties and photocytotoxicity evaluation against breast and gastric cancer cells","volume":"68","author":"Rabor","year":"2025","journal-title":"J. Med. Chem."},{"issue":"14","key":"10.1016\/j.jinorgbio.2026.113295_bb0065","doi-asserted-by":"crossref","first-page":"14239","DOI":"10.1021\/acs.jmedchem.4c02877","article-title":"LAMP2-mediated autophagy plasticity deters lysosomal uptake of platinum ions to reverse cisplatin-induced glioma progression in a macrophage dependent manner","volume":"68","author":"Hu","year":"2025","journal-title":"J. Med. Chem."},{"issue":"14","key":"10.1016\/j.jinorgbio.2026.113295_bb0070","doi-asserted-by":"crossref","first-page":"14995","DOI":"10.1021\/acs.jmedchem.5c01170","article-title":"Precision-oriented theophylline-platinum(IV) prodrugs: eliciting synthetic lethality in BRCA1-deficient ovarian cancer with enhanced efficacy and reduced toxicity in vitro and in vivo","volume":"68","author":"Liu","year":"2025","journal-title":"J. Med. Chem."},{"issue":"13","key":"10.1016\/j.jinorgbio.2026.113295_bb0075","doi-asserted-by":"crossref","first-page":"13455","DOI":"10.1021\/acs.jmedchem.5c00086","article-title":"Platinum(IV) prodrug with a docosahexaenoic acid ligand preferentially accumulates in drug-resistant cells and triggers ferroptosis to overcome drug resistance","volume":"68","author":"Zhou","year":"2025","journal-title":"J. Med. Chem."},{"issue":"9","key":"10.1016\/j.jinorgbio.2026.113295_bb0080","doi-asserted-by":"crossref","first-page":"9661","DOI":"10.1021\/acs.jmedchem.5c00352","article-title":"Fluoxetine-conjugated platinum(IV) prodrugs targeting eEF2K and conquering multidrug resistance against triple-negative breast cancer","volume":"68","author":"Wang","year":"2025","journal-title":"J. Med. Chem."},{"issue":"8","key":"10.1016\/j.jinorgbio.2026.113295_bb0085","doi-asserted-by":"crossref","first-page":"8208","DOI":"10.1021\/acs.jmedchem.4c02909","article-title":"Pt(IV)-PROTAC complexes with synergistic antitumor activity and enhanced membrane permeability","volume":"68","author":"Li","year":"2025","journal-title":"J. Med. Chem."},{"issue":"5","key":"10.1016\/j.jinorgbio.2026.113295_bb0090","doi-asserted-by":"crossref","first-page":"5597","DOI":"10.1021\/acs.jmedchem.4c02840","article-title":"Discovery of a novel EF24 analogue-conjugated Pt(IV) complex as multi-target Pt(IV) prodrugs aims to enhance anticancer activity and overcome cisplatin resistance","volume":"68","author":"Wang","year":"2025","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.jinorgbio.2026.113295_bb0095","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2025.117734","article-title":"The anti-neoplastic potency of epoxy-substituted polyaromatic platinum(II) and platinum(IV) complexes against A549 lung cancer cells","volume":"294","author":"Al Sayegh","year":"2025","journal-title":"Eur. J. Med. Chem."},{"issue":"28","key":"10.1016\/j.jinorgbio.2026.113295_bb0100","doi-asserted-by":"crossref","DOI":"10.1002\/anie.202505930","article-title":"Evoking simultaneous ferroptosis and apoptosis by a dual-locked platinum (IV) prodrug for synergistic chemo-immunotherapy","volume":"64","author":"Meng","year":"2025","journal-title":"Angew. Chem. Int. Ed."},{"issue":"42","key":"10.1016\/j.jinorgbio.2026.113295_bb0105","doi-asserted-by":"crossref","first-page":"18556","DOI":"10.1002\/anie.202005362","article-title":"CAIXplatins: highly potent platinum(IV) prodrugs selective against carbonic anhydrase IX for the treatment of hypoxic tumors","volume":"59","author":"Cao","year":"2020","journal-title":"Angew. Chem. Int. Ed."},{"issue":"9","key":"10.1016\/j.jinorgbio.2026.113295_bb0110","doi-asserted-by":"crossref","first-page":"9162","DOI":"10.1021\/acs.jmedchem.4c02509","article-title":"Platinum(IV) complexes trigger death receptors and natural killer cells to suppress breast cancer","volume":"68","author":"Cai","year":"2025","journal-title":"J. Med. Chem."},{"issue":"12","key":"10.1016\/j.jinorgbio.2026.113295_bb0115","doi-asserted-by":"crossref","first-page":"8227","DOI":"10.1021\/acs.jmedchem.1c02136","article-title":"Pt(IV) prodrugs with non-steroidal anti-inflammatory drugs in the axial position","volume":"65","author":"Spector","year":"2022","journal-title":"J. Med. Chem."},{"issue":"8","key":"10.1016\/j.jinorgbio.2026.113295_bb0120","first-page":"1326","article-title":"Prospects for ferroptosis therapies in cancer","volume":"6","author":"Ubellacker","year":"2025","journal-title":"Nat. Can."},{"issue":"5","key":"10.1016\/j.jinorgbio.2026.113295_bb0125","doi-asserted-by":"crossref","first-page":"2179","DOI":"10.7150\/ijbs.105446","article-title":"Mitochondrial regulation of ferroptosis in cancer cells","volume":"21","author":"Ding","year":"2025","journal-title":"Int. J. Biol. Sci."},{"key":"10.1016\/j.jinorgbio.2026.113295_bb0130","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2025.217697","article-title":"Glutathione metabolism in ferroptosis and cancer therapy","volume":"621","author":"Xue","year":"2025","journal-title":"Cancer Lett."},{"issue":"1","key":"10.1016\/j.jinorgbio.2026.113295_bb0135","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1186\/s13046-025-03520-6","article-title":"Targeting the interplay of cGAS-STING and ferroptosis by nanomedicine in the treatment of cancer","volume":"44","author":"Li","year":"2025","journal-title":"J. Exp. Clin. Cancer Res."},{"issue":"4","key":"10.1016\/j.jinorgbio.2026.113295_bb0140","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1007\/s42114-025-01402-1","article-title":"Functional artemisinin derivative-engineered nanohybrids boost ferroptosis stress-driven cancer therapy","volume":"8","author":"Wang","year":"2025","journal-title":"Adv. Compos. Hybrid Mater."},{"issue":"7","key":"10.1016\/j.jinorgbio.2026.113295_bb0145","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1016\/j.devcel.2025.02.004","article-title":"Mechanisms of ferroptosis sensitization and resistance","volume":"60","author":"Lee","year":"2025","journal-title":"Dev. Cell"},{"key":"10.1016\/j.jinorgbio.2026.113295_bb0150","doi-asserted-by":"crossref","DOI":"10.1016\/j.drup.2022.100916","article-title":"Overcoming cancer chemotherapy resistance by the induction of ferroptosis","volume":"66","author":"Wang","year":"2023","journal-title":"Drug Resist. Updat."},{"issue":"7","key":"10.1016\/j.jinorgbio.2026.113295_bb0155","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1038\/s41568-019-0149-1","article-title":"Ferroptosis at the crossroads of cancer-acquired drug resistance and immune evasion","volume":"19","author":"Friedmann Angeli","year":"2019","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.jinorgbio.2026.113295_rf0160","doi-asserted-by":"crossref","DOI":"10.1016\/j.critrevonc.2025.104906","article-title":"Cysteine metabolism at the crossroads of ferroptosis and cancer therapy","volume":"215","author":"Lee","year":"2025","journal-title":"Crit. Rev. Oncol. Hematol."},{"key":"10.1016\/j.jinorgbio.2026.113295_rf0165","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2023.115968","article-title":"Novel platinum(IV) complexes intervene oxaliplatin resistance in colon cancer via inducing ferroptosis and apoptosis","volume":"263","author":"Liu","year":"2024","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.jinorgbio.2026.113295_rf0170","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2025.114331","article-title":"Regulating ferroptosis by roflumilast attenuates cisplatin-induced kidney injury","volume":"151","author":"Abdel-Rahman","year":"2025","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.jinorgbio.2026.113295_rf0175","doi-asserted-by":"crossref","DOI":"10.1016\/j.ccr.2023.215578","article-title":"Platinum(IV) and platinum(II) anticancer complexes with biologically active releasable ligands","volume":"501","author":"\u0160tarha","year":"2024","journal-title":"Coord. Chem. Rev."},{"key":"10.1016\/j.jinorgbio.2026.113295_rf0180","article-title":"Platinum(IV) and platinum(II) anticancer complexes with biologically active releasable ligands","volume":"442","author":"Xu","year":"2021","journal-title":"Coord. Chem. Rev."},{"key":"10.1016\/j.jinorgbio.2026.113295_rf0185","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.ejmech.2019.02.063","article-title":"Multifunctional platinum(IV) complexes as immunostimulatory agents to promote cancer immunochemotherapy by inhibiting tryptophan-2,3-dioxygenase","volume":"169","author":"Hua","year":"2019","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.jinorgbio.2026.113295_rf0190","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1039\/C8MT00296G","article-title":"Multifunctional Pt(IV) complexes containing a glutathione S-transferase inhibitor lead to enhancing anticancer activity and preventing metastasis of osteosarcoma cells","volume":"11","author":"Chen","year":"2019","journal-title":"Metallomics"},{"issue":"9","key":"10.1016\/j.jinorgbio.2026.113295_rf0195","doi-asserted-by":"crossref","first-page":"4348","DOI":"10.1002\/ptr.70004","article-title":"4\u2032-hydroxychalcone induces ferroptosis in glioblastoma through the xCT\/GSH\/ GPX4 axis under the regulation of the AKT\/mTORC1\/4EBP1 pathway","volume":"39","author":"Zhao","year":"2025","journal-title":"Phytother. Res."},{"issue":"5","key":"10.1016\/j.jinorgbio.2026.113295_rf0200","doi-asserted-by":"crossref","first-page":"3393","DOI":"10.1021\/acs.jmedchem.2c01895","article-title":"Development of clioquinol platinum(IV) conjugates as autophagy-targeted antimetastatic agents","volume":"66","author":"Zhang","year":"2023","journal-title":"J. Med. Chem."},{"issue":"11","key":"10.1016\/j.jinorgbio.2026.113295_rf0205","doi-asserted-by":"crossref","first-page":"6096","DOI":"10.1021\/acs.jmedchem.0c00343","article-title":"Anticancer melatplatin prodrugs: high effect and low toxicity, MT1-ER-target and immune response in vivo","volume":"63","author":"Song","year":"2020","journal-title":"J. Med. Chem."},{"issue":"11","key":"10.1016\/j.jinorgbio.2026.113295_rf0210","doi-asserted-by":"crossref","first-page":"7933","DOI":"10.1021\/acs.jmedchem.2c00472","article-title":"Platinum(IV) prodrugs with cancer stem cell inhibitory effects on lung cancer for overcoming drug resistance","volume":"65","author":"Wang","year":"2022","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.jinorgbio.2026.113295_bb0175","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2021.113730","article-title":"Targeting ROS-AMPK pathway by multiaction platinum(IV) prodrugs containing hypolipidemic drug bezafibrate","volume":"223","author":"Qiao","year":"2021","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.jinorgbio.2026.113295_bb0180","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2021.104741","article-title":"Dual-target platinum(IV) complexes exhibit antiproliferative activity through DNA damage and induce ER-stress-mediated apoptosis in A549 cells","volume":"110","author":"Wang","year":"2021","journal-title":"Bioorg. Chem."},{"issue":"6","key":"10.1016\/j.jinorgbio.2026.113295_bb0185","doi-asserted-by":"crossref","first-page":"4687","DOI":"10.1021\/acs.jmedchem.1c01775","article-title":"Discovery of a novel stilbene derivative as a microtubule targeting agent capable of inducing cell ferroptosis","volume":"65","author":"Zhou","year":"2022","journal-title":"J. Med. Chem."},{"issue":"12","key":"10.1016\/j.jinorgbio.2026.113295_rf0230","doi-asserted-by":"crossref","first-page":"8066","DOI":"10.1021\/acs.jmedchem.3c00396","article-title":"Discovery of platinumIV-artesunate multiaction prodrugs as potent antitumor and antimalarial agents","volume":"66","author":"Liu","year":"2023","journal-title":"J. Med. Chem."},{"issue":"21","key":"10.1016\/j.jinorgbio.2026.113295_rf0235","doi-asserted-by":"crossref","first-page":"5227","DOI":"10.1021\/jm0708275","article-title":"Calculation of lipophilicity of a large, diverse dataset of anticancer platinum complexes and the relation to cellular uptake","volume":"50","author":"Oldfield","year":"2007","journal-title":"J. Med. Chem."},{"issue":"2","key":"10.1016\/j.jinorgbio.2026.113295_rf0240","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1021\/jm00106a056","article-title":"Hydrophobicity parameters for platinum complexes","volume":"34","author":"Souchard","year":"1991","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.jinorgbio.2026.113295_rf0245","doi-asserted-by":"crossref","first-page":"1580","DOI":"10.1021\/acs.inorgchem.5b02484","article-title":"Investigation of the inertness to hydrolysis of platinum(IV) prodrugs","volume":"55","author":"Ritacco","year":"2016","journal-title":"Inorg. Chem."},{"issue":"12","key":"10.1016\/j.jinorgbio.2026.113295_rf0250","doi-asserted-by":"crossref","first-page":"10190","DOI":"10.1021\/acs.jmedchem.4c00366","article-title":"Discovery of the next-generation platinum-based anticancer agents for combating oxaliplatin-induced drug resistance","volume":"67","author":"Sun","year":"2024","journal-title":"J. Med. Chem."},{"issue":"16","key":"10.1016\/j.jinorgbio.2026.113295_rf0255","doi-asserted-by":"crossref","first-page":"6678","DOI":"10.1021\/acs.jmedchem.5b00910","article-title":"Scaffold diversity inspired by the natural product evodiamine: discovery of highly potent and multitargeting antitumor agents","volume":"58","author":"Wang","year":"2015","journal-title":"J. Med. Chem."},{"issue":"2","key":"10.1016\/j.jinorgbio.2026.113295_rf0260","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1021\/acs.jmedchem.9b01626","article-title":"Scaffold hopping of natural product evodiamine: discovery of a novel antitumor scaffold with excellent potency against colon cancer","volume":"63","author":"Wang","year":"2020","journal-title":"J. Med. Chem."},{"issue":"5","key":"10.1016\/j.jinorgbio.2026.113295_rf0265","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1021\/jm8000983","article-title":"Synthesis, cytotoxicity, and DNA interactions of new cisplatin analogues containing substituted benzimidazole ligands","volume":"52","author":"G\u00fcm\u00fc\u015f","year":"2009","journal-title":"J. Med. Chem."},{"issue":"5","key":"10.1016\/j.jinorgbio.2026.113295_rf0270","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1021\/jm8000983","article-title":"Synthesis, cytotoxicity, and DNA interactions of new cisplatin analogues containing substituted benzimidazole ligands","volume":"52","author":"G\u00fcm\u00fc\u015f","year":"2009","journal-title":"J. Med. Chem."},{"issue":"4","key":"10.1016\/j.jinorgbio.2026.113295_rf0275","doi-asserted-by":"crossref","first-page":"2758","DOI":"10.1021\/acs.jmedchem.3c01890","article-title":"Design, synthesis, and biological evaluation for first GPX4 and CDK dual inhibitors","volume":"67","author":"Zhu","year":"2024","journal-title":"J. Med. Chem."},{"issue":"16","key":"10.1016\/j.jinorgbio.2026.113295_bb0205","doi-asserted-by":"crossref","first-page":"11201","DOI":"10.1021\/acs.jmedchem.3c00659","article-title":"Marine alkaloid lepadins E and H induce ferroptosis for cancer chemotherapy","volume":"66","author":"Wang","year":"2023","journal-title":"J. Med. Chem."},{"issue":"14","key":"10.1016\/j.jinorgbio.2026.113295_bb0210","doi-asserted-by":"crossref","first-page":"10014","DOI":"10.1021\/acs.jmedchem.2c00664","article-title":"Seco-lupane triterpene derivatives induce ferroptosis through GPX4\/ACSL4 axis and target cyclin D1 to block the cell cycle","volume":"65","author":"Wang","year":"2022","journal-title":"J. Med. Chem."},{"issue":"2","key":"10.1016\/j.jinorgbio.2026.113295_bb0215","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1021\/acs.jmedchem.3c01709","article-title":"Deciphering the diversified metabolic behavior of hydroxyalkyl ferrocidiphenols as anticancer complexes","volume":"67","author":"Wang","year":"2024","journal-title":"J. Med. Chem."},{"issue":"23","key":"10.1016\/j.jinorgbio.2026.113295_bb0220","doi-asserted-by":"crossref","first-page":"27769","DOI":"10.1021\/acsanm.4c06164","article-title":"Tumor microenvironment-responsive ternary nanosystem for enhanced antitumor and antimetastasis efficacy against breast cancer","volume":"7","author":"Hou","year":"2024","journal-title":"ACS Appl. Nano Mater."},{"key":"10.1016\/j.jinorgbio.2026.113295_bb0225","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.ejmech.2019.02.063","article-title":"Multifunctional platinum(IV) complexes as immunostimulatory agents to promote cancer immunochemotherapy by inhibiting tryptophan-2,3-dioxygenase","volume":"169","author":"Hua","year":"2019","journal-title":"Eur. J. Med. Chem."},{"issue":"21","key":"10.1016\/j.jinorgbio.2026.113295_bb0230","doi-asserted-by":"crossref","first-page":"14692","DOI":"10.1021\/acs.jmedchem.2c01224","article-title":"Pt(IV)-deferasirox prodrug combats DNA damage repair by regulating RNA N6-methyladenosine methylation","volume":"65","author":"Pan","year":"2022","journal-title":"J. Med. Chem."},{"issue":"11","key":"10.1016\/j.jinorgbio.2026.113295_bb0235","doi-asserted-by":"crossref","first-page":"7933","DOI":"10.1021\/acs.jmedchem.2c00472","article-title":"Platinum(IV) prodrugs with cancer stem cell inhibitory effects on lung cancer for overcoming drug resistance","volume":"65","author":"Wang","year":"2022","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.jinorgbio.2026.113295_bb0240","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2021.113520","article-title":"Novel Pt(IV) complexes to overcome multidrug resistance in gastric cancer by targeting P-glycoprotein","volume":"221","author":"Cao","year":"2021","journal-title":"Eur. J. Med. Chem."},{"issue":"4","key":"10.1016\/j.jinorgbio.2026.113295_bb0245","doi-asserted-by":"crossref","first-page":"4352","DOI":"10.1021\/acs.jmedchem.4c02116","article-title":"Novel indoleamine-2,3-dioxygenase-targeted Pt(IV) prodrugs regulate the tumor immune microenvironment to achieve chemoimmunotherapy in vitro and in vivo","volume":"68","author":"Li","year":"2025","journal-title":"J. Med. Chem."}],"container-title":["Journal of Inorganic Biochemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S016201342600084X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S016201342600084X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,20]],"date-time":"2026-05-20T04:39:27Z","timestamp":1779251967000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S016201342600084X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":64,"alternative-id":["S016201342600084X"],"URL":"https:\/\/doi.org\/10.1016\/j.jinorgbio.2026.113295","relation":{},"ISSN":["0162-0134"],"issn-type":[{"value":"0162-0134","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Multifunctional platinum(IV) complexes reverse cisplatin resistance in triple- negative breast cancer via ferroptosis and apoptosis","name":"articletitle","label":"Article Title"},{"value":"Journal of Inorganic Biochemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jinorgbio.2026.113295","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"113295"}}